Moussa Youdim
Executive Director
pharmaceutical
Youdim Pharmaceuticals
Israel
Biography
Prof. Moussa Youdim, a world-renowned expert in pharmacology, is Youdim’s Chairman. Prof. Youdim is the inventor and developer of the innovative Parkinson’s disease drug “Azilect”, Teva’s second largest innovative blockbuster, with annual revenues on $700M, and Selegiline, an MAO-B inhibitor for Parkinson’s disease treatment. Prof. Youdim has extensive experience in the pharmaceutical industry, professor emeritus at the Technion, where he was the head of the Department of Pharmacology at the Faculty of Medicine for over 30 years.
Research Interest
Pharmaceutical science